Company Filing History:
Years Active: 2024
Title: **Innovative Contributions of Yanbin Wang in Immune Cell Engineering**
Introduction
Yanbin Wang, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of immune cell engineering. With a focus on developing solutions for cancer, infections, and autoimmune diseases, his innovative work has the potential to revolutionize treatment methodologies.
Latest Patents
Wang holds a noteworthy patent for an engineered immune cell that expresses key components necessary for enhanced recognition and response to targeted threats. His patent, titled "Engineered immune cell and use thereof," details a novel design whereby the engineered immune cell incorporates (i) a cell surface molecule that specifically recognizes a ligand, (ii) an exogenous interleukin, and (iii) an exogenous Flt3L, XCL2, and/or XCL1. This unique configuration allows the engineered immune cell to exhibit significantly improved tumor-killing activity compared to traditional engineered immune cells.
Career Highlights
Currently employed at Bioheng Therapeutics Limited, Wang’s contributions reflect his dedication to advancing medical technology. His research and discoveries are crucial in the fight against complex medical challenges, particularly in oncology and autoimmune disease management. His patent indicates a strong commitment to innovation and the application of scientific knowledge to practical health solutions.
Collaborations
Throughout his career, Wang has collaborated with esteemed colleagues such as Yun Xing and Zhonghui Yan. These partnerships not only foster a dynamic research environment but also enhance the collective expertise driving forward the field of immune cell therapy at Bioheng Therapeutics Limited.
Conclusion
Yanbin Wang's inventive work represents a meaningful advancement in immune cell engineering, offering promising avenues for the treatment of cancer and related health issues. His patent and collaborative efforts exemplify his role as a pioneering inventor dedicated to improving therapeutic strategies and outcomes in modern medicine.